ATYR - aTyr Pharma, Inc.
NEXT EARNINGS:
Mar 12, 2026
(in 15 days)
EPS Est: $-0.18
|
Rev Est: $20000
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$1.17
DETAILS
HIGH:
$1.50
LOW:
$1.00
MEDIAN:
$1.00
CONSENSUS:
$1.17
UPSIDE:
18.33%
Market Cap:
96.89M
Volume:
1,330,225
Avg Volume:
2,170,673
52 Week Range:
0.64-7.29
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.58
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
56
IPO Date:
2015-05-07
EPS (TTM):
-0.86
P/E Ratio:
-4.20
Revenue (TTM):
235,000
Total Assets:
96.83M
Total Debt:
13.28M
Cash & Equiv:
11.05M
Rev Growth (5Y):
-11.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-83.0%
Debt/Equity:
0.19
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.26 | $-0.20 | -30.0% | $190000 | $20000 | +850.0% |
| 2025-08-07 | $-0.22 | $-0.18 | -22.2% | — | — | — |
| 2025-05-07 | $-0.17 | $-0.19 | +10.5% | — | — | — |
| 2025-03-13 | $-0.18 | $-0.23 | +21.7% | — | $15556 | — |
| 2024-11-07 | $-0.23 | $-0.22 | -4.5% | — | $21667 | — |
| 2024-08-13 | $-0.23 | $-0.22 | -4.5% | — | $20000 | — |
| 2024-05-02 | $-0.23 | $-0.24 | +4.2% | $235000 | $36667 | +540.9% |
| 2024-03-14 | $-0.25 | $-0.24 | -4.2% | — | $3.4M | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 235,000 | 353,000 | 10.39M | 0 | 10.46M | 422,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (64.02M) | (50.39M) | (45.34M) | (33.77M) | (16.22M) | (23.60M) | (34.52M) | (48.21M) | (57.85M) | (47.97M) | (24.35M) | (20.01M) |
| EPS | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 | -7.03 | -16.13 | -26.16 | -34.20 | -42.42 | -422.73 | -429.90 |
| Total Assets | 96.83M | 120.65M | 95.79M | 115.54M | 38.73M | 36.19M | 52.75M | 89.36M | 80.52M | 129.68M | 20.64M | 39.79M |
| Total Debt | 13.28M | 15.10M | 11.53M | 1.38M | 2.24M | 11.73M | 16.03M | 19.73M | 9.54M | 5.14M | 10.28M | 6.89M |
| Cash & Equivalents | 11.05M | 22.54M | 9.98M | 2.34M | 16.95M | 9.21M | 22.96M | 21.09M | 38.39M | 53.02M | 13.90M | 36.46M |
| Operating Cash Flow | (69.12M) | (33.22M) | (41.89M) | (33.08M) | (15.30M) | (20.01M) | (31.06M) | (42.36M) | (52.86M) | (36.80M) | (22.82M) | (17.31M) |
| Free Cash Flow | (69.18M) | (37.44M) | (43.53M) | (33.27M) | (15.50M) | (20.09M) | (31.66M) | (43.68M) | (53.46M) | (37.46M) | (23.07M) | (17.95M) |
| FCF per Share | -0.93 | -0.70 | -1.53 | -1.74 | -1.69 | -5.99 | -14.79 | -23.70 | -31.61 | -33.11 | -393.83 | -356.51 |
| Book Value | 70.02M | 90.66M | 71.46M | 109.30M | 31.65M | 21.19M | 33.65M | 64.25M | 62.80M | 115.05M | (91.01M) | (68.50M) |
| Cash & ST Investments | 72.12M | 98.17M | 66.15M | 107.91M | 31.69M | 31.14M | 49.55M | 85.12M | 72.15M | 95.53M | 15.85M | 36.46M |
| ROC Equity | -0.91 | -0.56 | -0.63 | -0.31 | -0.51 | -1.11 | -1.03 | -0.75 | -0.92 | -0.42 | N/A | N/A |